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An essential role of PI3K in the 
control of West Nile virus infection
Leilei Wang1,2, Long Yang1, Erol Fikrig3,4 & Penghua Wang1
The phosphatidyl-inositol-3 kinases (PI3K) pathway regulates a variety of cellular processes, including 
cell proliferation, RNA processing, protein translation, autophagy, apoptosis and antiviral immunity. 
Many viruses depend on PI3K signaling for replication. However, its role in flaviviral infection has not 
been clearly defined. Here we report that PI3K signaling is critical for the control of West Nile virus 
(WNV) infection by regulating type I IFN (IFN-I) response. Inhibition of PI3K activity by 3-methyl 
adenine (3-MA), Wortmannin (WM) and LY294002 (LY) increased viral titers by 3–16 folds in primary 
mouse macrophages, embryonic fibroblasts and human cell lines. Both 3-MA and LY repressed IFN-I 
mRNA and protein expression significantly. Surprisingly, WM enhanced the mRNA expression of IFN-I 
and TNF-α, and TNF-α protein production modestly, while dramatically decreased the secreted IFN-
I. Further studies showed that the catalytic subunit p110δ of class I PI3K played a role in induction of 
antiviral immune responses. Lastly translocation of interferon regulatory factor 7(IRF7) from the cytosol 
to the nuclei was effectively blocked in the presence of PI3K inhibitors. Our results clearly define an 
antiviral role of PI3K by modulating immune responses and demonstrate differential mode of action of 
three PI3K inhibitors on IFN-I.
WNV is an enveloped, single stranded, positive-sense RNA virus, belonging to the Flaviviridae family, which 
includes a number of medically important human pathogens of global epidemiological importance such as hep-
atitis C (HCV), dengue (DENV), Zika virus (ZIKV), yellow fever (YFV), Japanese encephalitis (JEV), St. Louis 
encephalitis (SLEV), and tick-borne encephalitis (TBEV) viruses. WNV has been more widely recognized since 
1999 when it was first introduced into North America and was accountable for 7 deaths1. WNV can now be 
found all over the United States continent, and has been associated with over 21,000 encephalitis/meningitis cases 
and 1,800 deaths (https://www.cdc.gov/westnile/statsmaps/index.html). The mortality for the population over 70 
years old can be as high as 15% to 29%2. Moreover 50% of those elderly who survived WNV infection may have 
significant post-illness morbidity for at least a year3. However, current therapeutic options for WNV disease are 
mainly supportive4, due to lack of effective vaccines and specific antiviral drugs.
Host control of WNV infection depends on the innate immune system during the acute phase and on the 
antibody response later3, 5. The phosphatidyl-inositol-3 kinases (PI3K)/ serine/threonine kinase (Akt) pathway 
regulates a variety of cellular processes, including cell proliferation, RNA processing, protein translation, auto-
phagy and apoptosis6–9. It also plays an important role in induction of antiviral responses. For instance, vesicular 
stomatitis virus (VSV), Toll like receptor 3 (TLR3) and TLR4 agonists induced phosphorylation of IFN regulatory 
factor 3 (IRF3) via the PI3K/Akt pathway10, 11, and subsequent type I interferon (IFN-I) response, a critical antivi-
ral mechanism. In addition, PI3K/Akt is essential for TLR3-mediated tyrosine phosphorylation, and RIG-I (RLR) 
dependent IRF3 activation in response to double/single –stranded RNA (ds/ss RNA) viruses12–15. On the other 
hand, PI3K/Akt signaling promotes cellular survival and autophagy16, another important cell-intrinsic antiviral 
mechanism17. Hepatitis B was reported to activate the PI3K pathway and thus inhibit TGFβ-induced apoptosis15. 
Another study showed that two faviviruses, JEV and DEN-2 activated the PI3K/Akt pathway and then blocked 
early apoptotic cell death18. The role of the PI3K/Akt pathway in WNV pathogenesis remains elusive. We investi-
gated the role of PI3K in WNV pathogenesis and immune responses in primary mouse macrophages which con-
stitute an important fraction of the inflammatory infiltrate seen in the central nervous system of WNV patients19, 
primary embryonic fibroblasts and two human cell lines. We found that PI3K inhibitors significantly enhanced 
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WNV replication, and simultaneously repressed IFN-I protein production. Furthermore, we demonstrated that 
the inhibitor of the catalytic subunit p110δ of class I PI3K decreased IFN-I significantly. Lastly translocation of 
interferon regulatory factor 7(IRF7) from the cytosol to the nuclei was effectively blocked in the presence of PI3K 
inhibitors. Our results show that PI3K signaling is critical for the control of WNV infection by modulating IFN-I 
response.
Results
PI3K signaling is critical for the control of West Nile virus infection by modulating type I IFNs 
response. On one hand, PI3K/Akt signaling is critical for many viruses to complete their life cycle, including 
cellular entry, replication and egress16. On the other hand, the PI3K/Akt pathway also induces antiviral immunity, 
particularly type I interferon (IFN-I) response10, 11. However, the exact role (favorable or unfavorable for virus 
infection) of the PI3K/Akt pathway may be virus-specific. We tested West Nile virus (WNV), a reemerging flavi-
virus of significant public health concern in the United States. Treatment of cells with a PI3K inhibitor, 3-meth-
yladenine (3-MA), enhanced WNV titers by 3–16 folds in a dose dependent manner (Fig. 1). Two other pan-PI3K 
inhibitors, Wortmannin (WM) and LY294002 (LY) also increased viral infection by more than 4 times. These data 
clearly demonstrate that the PI3K/Akt pathway is essential for prevention of WNV infection. We next asked how 
PI3K controls WNV infection. PI3K may prevent viral infection by inducing cell-intrinsic antiviral mechanisms 
such as IFN-I response18 and autophagy16. Indeed, both secreted TNF-α and IFN-β protein concentrations in 
the cell culture medium decreased dramatically after 3-MA treatment in a dose dependent manner (Fig. 2A). 
At the mRNA level, Ifna was most dramatically repressed by 3-MA treatment (4 and10 times at 1 mM and 2 mM 
respectively); Ifnb1 was down-regulated modestly by 2–3 times. However, Tnfa, Tlr3, Ddx58 and Dhx58 mRNA 
expression was not significantly influenced by 3-MA at any concentrations (Fig. 2B). In the case of Wortmannin 
treatment, IFN-β protein concentration was reduced by 4 times (Fig. 2C), but Ifnb1, Ifna and Tlr3 mRNA expres-
sion was up-regulated slightly; Ddx58 and Dhx58 remained unchanged (Fig. 2D). Surprisingly, TNF-α protein 
abundance and mRNA expression was increased in the presence of WM in a dose dependent manner (Fig. 2C,D). 
Both TNF-α and IFN-β protein concentrations were also reduced significantly by LY294002 treatment, while 
IFN-β mRNA level was modestly downregulated (Fig. 2E,F). To see if the anti-WNV function of PI3K is universal 
or cell type-specific, we examined WNV infection with/without 3-MA treatment in primary mouse embryonic 
fibroblasts (MEFs) and two human cell lines, H1975 (lung epithelial cells) and THP-1 (macrophage-like mono-
cytes). IFN-β mRNA induction by WNV was dramatically repressed in the presence of 3-MA and viral replication 
was enhanced at 12 and 24 h after infection in all the cell types (Fig. 3A–C). The Ddx58 mRNA level was 5-fold 
lower in 3-MA than mock-treated MEFs at 12 h after infection (Fig. 3A). Together, these results suggest that PI3K 
can inhibit WNV replication through modulating IFN-I response.
PI3K regulates IRF7 nuclear translocation. The family of PI3Ks is grouped into 4 classes, with class I 
being extensively studied16. The class I PI3K catalytic p110 subunit has 4 isoforms: α, β, γ and δ. To determine 
which isoform was important for IFN-Is induction after WNV infection, we examined the mRNA levels of all 
the four p110 subunits. Accompanied by increasing viral replication and immune response (Infb1 and Tnfa), 
p110α and p110β mRNA expression increased by 2–3 fold between 2–6 h after infection; while p110γ and p110δ 
remained unchanged during the course of infection (Fig. 4A). However, only p110δ inhibitor enhanced WNV 
replication by 4-fold and decreased TNF-α by 1.56 and IFN-β production by 1.8 fold at 1 µM, to a lesser extent 
than the pan-PI3K inhibitor LY290042 though (Fig. 4B–D). To validate the pharmacological results, we next used 
siRNA to knock down p110δ expression. We used two unique siRNA against p110β, p110δ and Vps34, all of which 
achieved >60% silencing efficiency (Fig. 5A). The p110β and Vps34 siRNA did not influence p110δ expression, 
suggesting specificity of the silencing effect (Fig. 5B). Consistent with the pharmacological inhibition (Fig. 4), 
p110δ knockdown enhanced viral replication by ~6 fold (Fig. 5C) and simultaneously decreased IFN-β produc-
tion by 4–11 times (Fig. 5D), compared to the negative (scrambled siRNA) controls. These results suggest that 
class I p110δ is the dominant catalytic subunit for IFN-I induction by WNV. To further investigate the mechanism 
of interferon induction by PI3K, we examined three transcription factors critical for IFN-I expression, interferon 
Figure 1. Inhibition of PI3K enhances WNV infection of bone marrow derived macrophages (BMDMs). 
BMDMs were infected with WNV in the presence of DMSO (None), or various concentrations of 
3-methyadenine (3-MA), Wortmannin (WM) and LY294002 (LY) for 24 h. The numbers of viral particles in 
the cell culture media are expressed as plaque forming units (PFU) per milliliter. *p < 0.05, **p < 0.001 (two-
tailed unpaired Student’s T-test), Bar: the mean of the result + s.e.m. The data shown are representative of 3 
independent reproducible experiments.
www.nature.com/scientificreports/
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regulatory factors (IRF) 3,−7 and NF-κB. We noted that WNV infection increased the protein amounts of IRF3, 
−7 and NF-κB in the nuclear fraction when compared to non-infected nuclear extracts. The amounts of nuclear 
IRF7 were reduced by 62% in the presence of LY294002, while IRF3 and NF-kB p65 was modestly decreased by 
17% (Fig. 6A,B). We confirmed IRF7 nuclear translocation deficiency by immunofluorescence microscopy: the 
intensity of nuclear IRF7 was lower in LY294002-treated WNV-infected cells than DMSO-treated WNV-infected 
cells (Fig. 6C).
Discussion
The PI3K/Akt pathway regulates a variety of cellular processes, including cell proliferation, RNA processing, pro-
tein translation, autophagy and apoptosis6. In order to replicate in host cells, viruses develop strategies to stimu-
late basal PI3K activity16. As an adaptive strategy, PI3K may activate IFN-I response and autophagy to counteract 
viral invasion. However, autophagy may be hijacked by viruses for their efficient replication, likely in a cell-type 
and virus specific manner 20. Autophagy is induced by WNV infection in many cell types including fibroblasts21, 
neurons22 and macrophages (our unpublished data); its role in WNV replication however is still controversial. 
One study showed that autophagy inhibited WNV replication in mouse embryonic fibroblasts infected with a 
low multiplicity of infection (MOI = 0.01)21. While other studies demonstrated that autophagy played no role 
in WNV replication in cell lines derived from kidney, liver, skin and23, and in IFN-I-deficient Vero/BHK and 
primary neuron cultures22. Inhibition of PI3K with 3-MA repressed WNV replication in primary neurons22, 
Figure 2. Inhibition of PI3K impairs WNV-induced immune responses in macrophages. BMDMs were left 
untreated (mock) or infected with WNV in the presence of various concentrations of (A,B) 3-methyadenine, 
(C,D) Wortmannin and (E,F) LY294002 for 24 h. (A,C,E) ELISA of TNF-α, IFN-β in the cell culture media. 
(B,D,F) The cellular viral loads and transcript levels of selected genes were quantified by q-PCR. The results of 
immune gene expression are expressed as fold induction in WNV infected cells over mock. The viral loads are 
expressed as fold change in inhibitor-treated over untreated cells (0). *p < 0.05, **p < 0.001 (unpaired Student’s 
T-test), Bar: the mean of the result + s.e.m. The data shown are representative of 3 independent reproducible 
experiments.
www.nature.com/scientificreports/
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suggesting PI3K signaling favors viral replication. In contrast to this report, our study shows that PI3K is critical 
for control of WNV replication and type I IFN response in primary macrophage, an important immune cell type 
that restricts WNV infection in vivo24 and several other cell types. Macrophages may control WNV infection by 
direct effector mechanisms such as the production of nitric oxide intermediates25 or production of IFN-I26. Our 
study indicates that PI3K positively regulates IFN-β protein expression.
Furthermore, we found that the modes of action of three pan-PI3K inhibitors on type I IFNs are differ-
ent. 3-MA and LY294002 interfere with IFN-I expression at both the transcriptional and translational level. 
Interestingly, although 3-MA reduces the TNF-α protein concentration in the culture media dramatically, it has 
no effect on TNF-α mRNA expression. A possible explanation may be that 3-MA interferes with TNF-α transla-
tion or secretion. In macrophages, TNF-α is transported to the cell surface where it is cleaved by TNF converting 
enzyme and released into extracellular milieu via constitutive exocytosis and recycling endosomes27–29 involving 
PI3Ks. Wortmannin does not influence type I IFN transcription significantly, but reduces protein abundance in 
the culture media. It is plausible that Wortmannin preferentially targets PI3Ks that are involved in IFN-I secre-
tion, which underlying mechanism is currently unknown. Wortmannin may also inhibit other kinases such as 
myosin light chain kinase (MLCK) and phosphatidylinositol 4-OH kinase (PI4K) that potentially play a role in 
exocytosis30, 31. Surprisingly Wortmannin enhances both TNF-α protein and mRNA expression, which may be 
Figure 3. Inhibition of PI3K impairs WNV-induced immune responses in mouse embryonic fibroblasts 
and human cells. (A) MEFs, (B) THP-1 and (C) H1975 cells were infected with WNV without (Ctrl) or with 
2 mM 3-MA for the indicated time. The cellular viral loads and transcript levels of selected immune genes 
were quantified by q-PCR. The results of immune gene expression are expressed as fold induction in WNV 
infected cells over mock (0 h). The viral loads are expressed as fold change over 12 h Ctrl cells. Bar: the mean 
of the result + s.e.m. *p < 0.05, **p < 0.001 (unpaired Student’s T-test). The data shown are representative of 2 
independent reproducible experiments.
www.nature.com/scientificreports/
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Figure 4. Selective inhibition of the PI3K catalytic p110 δ reduces antiviral immune responses. (A) The 
mRNA abundances of Ifnb1, Tnfa and p110 isoforms during the course of WNV infection were quantified by 
q-PCR. The results are expressed as fold change over uninfected (0 h after infection). (B–D) BMDMs were left 
untreated (mock) or infected with WNV in the presence of 5 µM of a pan-PI3K inhibitor LY294002 (All) or 
various concentrations of p110 isoform-specific inhibitors for 24 h. None: no inhibitor. (B) The cellular viral 
loads were quantified by q-PCR. The data are expressed as fold change over None. ELISA of (C) IFN-β and (D) 
TNF-α levels in the cell culture media. *p < 0.05, **p < 0.001 (unpaired Student’s T-test), Bar: the mean of the 
result + s.e.m. The data shown are representative of 3 independent reproducible experiments.
Figure 5. siRNA knock down of the PI3K catalytic p110 δ reduces antiviral immune responses. The scrambled 
(Neg) or p110-targeting siRNA was electroporated into BMDMs, 48 h later the BMDMs were infected with 
WNV for 24 h. (A,B) The mRNA abundances of p110 isoforms were quantified by q-PCR after WNV infection. 
The results are expressed as fold change over Neg in (A) or Mock transfected in (B). (C) The cellular viral loads 
were quantified by q-PCR. The data are expressed as fold change over Neg. (D) ELISA of IFN-β in the cell 
culture medium. UI, uninfected. *p < 0.05 (unpaired Student’s T-test), Bar: the mean of the result + s.e.m. The 
data shown are representative of 3 independent reproducible experiments.
www.nature.com/scientificreports/
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a secondary result of increased viral replication. Our results suggest that Wortmannin selectively interferes with 
IFN-I response and is a helpful tool for study of the molecular pathway governing type I IFN secretion.
Lastly, we identify the catalytic isoform of class I PI3K required for IFN-I induction. Inhibition of p110δ, but 
not other isoforms down-regulates type I IFN expression. However, the class I p110δ inhibitor is less potent than 
the pan-PI3K inhibitors to repress WNV-induced IFN-I expression, suggesting that other classes of PI3Ks also 
play a role. Consistent with our findings, it was recently shown that p110δ is essential for IFN-α production by 
plasmacytoid dendritic cells (pDCs) in response to TLR stimulation32.
In summary, our results clearly define an antiviral role for PI3K by modulating IFN-I immune responses and 
demonstrate differential mode of action of three PI3K inhibitors on IFN-I. Future work is to understand the 
molecular pathways governing IFN-I secretion using Wortmannin.
Materials and Methods
Cell culture and viral infection. All animal protocols were approved by the Institutional Animal Care & 
Use Committee at New York Medical College adhering to the National institutes of Health recommendations 
for the care and use of laboratory animals. Bone marrow derived macrophages (BMDMs) were differentiated as 
described previously33. Briefly, Bone marrows were isolated from the tibia and femur bones of 6 weeks old female 
C6/57BL (The Jackson Laboratory, # 000664. https://www.jax.org/strain/000664) and then differentiated into 
macrophages (BMDMs) in L929 (ATCC, #CCL-1) conditioned medium (RPMI1640, 20%FBS, 30% L929 culture 
medium, 1x antibiotics/antimycotics) in 10-cm Petri-dishes at 37 °C for 5 days. The attached BMDMs were dis-
lodged by pipetting and counted for plating. BMDMs were cultured in Roswell Park Memorial Institute (RPMI) 
1640 medium, Vero cells in DMEM, containing 10% (volume/volume) fetal bovine serum (FBS, Invitrogen, 
Carlsbad, CA), 100U/ml penicillin and 100 μg/ml streptomycin (Invitrogen) and maintained at 37 °C and 5% 
CO2. The WNV strain was a CT2741 isolate of NY199934 and propagated in C6/36 cells to generate a stock of 
~1 × 107 PFU/ml35. After differentiation, BMDMs were cultured in RPMI medium overnight, washed once with 
prewarmed fresh medium and then infected with WNV at a multiplicity of infection (MOI) of 10. After 1 hr at 
37 °C, the inoculum was replaced with fresh culture medium and cells were incubated at 37 °C. Cells and culture 
supernatants were collected at the indicated time points for further analyses.
For preparation of mouse embryonic fibroblasts (MEFs), day 14 embryos were decapitated and eviscerated 
then digested with trypsin for 10 min at 37 °C rotating. Fibroblasts were filtered through a 100 μM filter, cultured 
in RPMI1640 medium (Life Technologies, NY 14072 USA) supplemented with 10% fetal bovine serum and anti-
biotics/antimycotics, propagated for 2 passages and then frozen. MEFs were infected with WNV at a MOI of 1.
H1975 (human lung epithelial cell, Cat# CR5908) and THP-1 (human monocytes, Cat# TIB202) were pur-
chased from American Type Culture Collection (ATCC) (Manassas, VA20110, USA). These cells were cultured in 
RPMI1640 medium and infected with WNV at a MOI of 1 and 5 respectively.
Reagents and Antibodies. 3-Methyladenine (IC50 = 4.5 mM), Wortmannin (IC50 = 3 nM) and IC-87114 
(PI3K subunit p110δ, IC50 = 0.5 µM)) were purchased from Cayman Chemical (Ann Arbor, Michigan 48108, 
USA). LY294002 (IC50 = 1.0 µM), another PI3K inhibitor, was obtained from the Invivogen (San Diego, CA 92121, 
USA). The PI3-Kinase p110 α subunit inhibitor (B-0304, IC50 = 2 nM)), and γ inhibitor B-0302(IC50 = 250 nM) 
were from the Echelon (Salt Lake City, UT 84108, USA). The selective inhibitor of the P13K subunit p110 β, 
TGX-221(IC50 = 5 nM) was from EMD Millipore (Billerica, Massachusetts 01821, USA). Rabbit anti-IRF-7 
(H-246) was purchased from Santa Cruz Biotechnology (Dallas, TX 75220 USA). Rabbit anti-GAPDH 
(Cat #5174), IRF-3 (Cat # 4302) and NF-κB p65 (Cat #4764) antibodies were available from Cell Signaling 
Technology (Danvers, MA 01923 USA). Goat anti-MCM2 (Cat # A300-122) was from Bethyl Laboratories 
(Montgomery, TX 77356, USA). The siRNA oligonucleotides were purchased from Ambion of Thermo Fisher 
Figure 6. PI3K is critical for WNV-activated nuclear translocation of IRF7. BMDMs were left untreated (mock) 
or infected with WNV in the presence of vehicle control (DMSO) or 5 μM of LY294002 (LY) for 24 h. (A) 
Immunoblotting analyses of IRF3, IRF7, and NF- κBp65 in the cytoplasmic (Gapdh as the housekeeping protein 
control) and nuclear fractions (Mcm2 as the housekeeping protein control). Blots shown are cropped from full-
length. (B) Quantification of the nuclear immunoblot band density in (A) by Image J. The results are expressed 
as the ratio of IRF7/IRF3/p65 to Mcm2. (C) Immunofluorescence staining of IRF7 (red) and nuclei by DAPI 
(blue). Images were acquired with a Zeiss fluorescence microscope. The arrows indicate nuclear IRF7 staining. 
The data shown are representative of 3 independent reproducible experiments.
www.nature.com/scientificreports/
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Scientific. The sequences are p110b (ID: s93108, 5′-CAUAGAUUUUGGGCAUAUUTT-3′; ID: s93107, 
5′-GCAUAGCUGGUCUUCGUUUTT-3′), p110d (ID: s71605, 5′-CGAUGAAGCUGGUUGUUCATT-3′; 
I D :  s 7 1 6 0 6 ,  5 ′ - G C C G A A A A G U G A AU G C U G AT T- 3 ′ ) ,  a n d  Vp s 3 4  ( I D :  1 6 5 6 8 7 , 
5′-GCUUGCUCGGAGCUUAAGATT-3′; ID: 165688, 5′-CGAAGCUCUAAUUUCAUGUTT-3′).
Plaque forming assay. The detailed procedures of plaque forming assay were described previously36. Briefly, 
serially diluted culture supernatants from infected cells were inoculated into monolayers of type I IFN deficient 
Vero cells (ATCC # CCL-81). After 1 h of incubation at 37 °C, the inoculums were removed, and overlay medium 
(DMEM containing 10% FBS and 1% Seaplaque agarose) was added and incubated at 37 °C for 4 days. Plaques 
were visualized after Neutral Red (Sigma-Aldrich) staining on a white transilluminator.
ELISA. Commercial enzyme-linked immunosorbent assay (ELISA) kit were used to measure levels of secreted 
TNF-α (Cat # 88-7324, Affimetrix, San Diego, CA 92121USA) and INF-β (Cat# 42400, PBL Assay Sciences, 
Piscataway Township, NJ 08854 USA) proteins in the cell culture supernatants. The procedures were exactly the 
same as described in the product manuals.
Quantitative RT-PCR. RNA was extracted following the QIAGEN manual exactly, reverse-transcribed 
into cDNA using the BIO-RAD iScript™ cDNA Synthesis Kit. qPCR was performed with gene-specific prim-
ers and 6FAM-TAMRA (6-carboxyfluorescein–N,N,N,N-tetramethyl-6-carboxyrhodamine) probes, or primers 
(See Table 1) and SYBR-Green master mix on a BIO-RAD CFX96 Touch™ Real-Time PCR Detection System35. 
The PCR conditions were 50 °C for 2 min, 95 °C for 10 min, 40 cycles of 95 °C for 15 s, and 60 °C for 30 s. Results 
were calculated using the −ΔΔCt method and beta actin gene as an internal control. Primers and probes are 
listed in Table 1. The following primer/probe (6FAM-MGB) premixes were obtained from Applied Biosystems of 
Thermo Fisher Scientific: p110d, Mm00435674_m1; p110b, Mm00659576_m1; p110g, Mm00445038_m1; p110a, 
Mm00435669_m1; Vps34, Mm00619489_m1; Tlr3, Mm01207404_m1; Ddx58, Mm01216853_m1; Dhx58, 
Mm01302252_m1.
siRNA transfection and infection. BMDMs were transfected with siRNA and a mouse macrophage 
transfection Kit (Lonza #VPA-1009) on a Nucleofector 2. Briefly, differentiated BMDMs were dislodged gently 
from Petri dishes and counted using trypan blue staining. 1 × 106 cells were centrifuged at 200 × g for 10 min-
utes at room temperature. The resultant supernatant was discarded completely and the cell pellet was washed 
once with 1 ml sterile PBS. PBS was completely removed. The cell pellet was re-suspended carefully in 100 µl 
room temperature Nucleofector Solution VPA-1009 and 200 pmol siRNA per sample. The mix was transferred 
into a certified cuvette (sample must cover the bottom of the cuvette without air bubbles) and electroporated 
with a Nucleofector II using program Y-001. ~500 µl of the pre-equilibrated culture medium was added to the 
cuvette and then gently transferred to a 12-well cell culture plate. 48 h after transfection, the cells were infected 
with WNV for 24 h.
Nuclear extraction. 5 × 106 cells were scraped off from culture dishes and washed with ice cold phos-
phate buffered saline (PBS) twice. The cells were then resuspended gently in 500 μl 1x Hypotonic Buffer (20 mM 
Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl2, plus protease inhibitors) by pipetting up and down several times 
and then incubated on ice for 15 minutes. 25 μl detergent (10% NP40) was added to the cell suspension, which was 
then vortexed for 10 seconds at highest setting. The homogenate was centrifuged for 10 minutes at 3,000 rpm at 
4 °C, resulting in supernatant (cytosol) and pellet (nuclei). The nuclei were lyzed in 50 μl complete Cell Extraction 
Buffer (10 mM Tris, pH 7.4, 2 mM Na3VO4, 100 mM NaCl, 1% Triton X-100, 1 mM EDTA, 10% glycerol
1 mM EGTA, 0.1% SDS, 1 mM NaF, 0.5% deoxycholate, 20 mM Na4P2O7, complete protease inhibitors) for 
30 minutes on ice with intermittent vortexing every 10 minute. The lysate was then centrifuged for 30 minutes at 
14,000 × g at 4 °C, resulting in nuclear lysate (supernatant).
Western blotting. For immunoblotting, cells were harvested at indicated time points after WNV infec-
tion, lysed in lysis buffer buffer [50 mM Tris–HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 1% Triton X-100] 
supplemented with Complete Protease Inhibitor Cocktail (Roche Diagnostics, Indianapolis, IN). Cell lysates 
were resolved on a 4- to 15%-gradient SDS-PAGE gel, and the separated proteins were transferred to a nitro-
cellulose membrane. The proteins of interest on the membrane were probed with specific antibodies, followed 
by HRP-conjugated secondary antiserum, and detected with an enhanced chemilumiscence system from GE 
Healthcare (Port Washington, NY 11050 USA).
Gene symbol Forward 5′-3′ Reverse 5′-3′ Probe 5′-6FAM, 3′-TAMRA
Mm Actb AGAGGGAAATCGTGCGTGAC CAATAGTGATGATGACCTGGCCGT CACTGCCGCATCCTCTTCCTCCC
Mm Ifna CTTCCACAGGATCACTGTGTACCT TTCTGCTCTGACCACCTCCC AGAGAGAAGAAACACAGCCCCTGTGCC
Mm Ifnb1 CTGGAGCAGCTGAATGGAAAG CTTCTCCGTCAT CTCCATAGGG CAACCTCACCTACAGGGCGGACTTCAAG
MmTnfa CTCCAGGCGGTGCCTATGT GAAGAGCGTGGTGGCCC CAGCCTCTTCTCATTCCTGCTTGTGGC
WNV-E TTCTCGAAGGCGACAGCTG CCGCCTCCATATTCATCATC ATGTCTAAGGACAAGCCTACCATC
Table 1. Primers and probes.
www.nature.com/scientificreports/
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Immunofluorescence microscopy. For immunofluorescence assay, macrophages were fixed with 4% par-
aformaldehyde (PFA) in phosphate buffered saline for 10 min. The cells were sequentially permeabilized with 
0.5% Triton X-100, blocked with 2% goat serum, incubated with primary antibody (rabbit anti-IRF7 at 1:100 
dilution,) at 4 °C overnight, incubated with Alexa Fluor 488-conjugated goat anti-rabbit IgGs (Life Technologies 
Cat #A11070) for 1 h at room temperature. Nuclei were counter stained with DAPI. Images were acquired using a 
Zeiss fluorescence microscope with a 40x objective (Oberkochen, Germany).
Graphing and statistics. Prism 7 software (GraphPad Software) was used for charts and statistical analyses. 
A standard two-tailed unpaired Student’s t-test was used to calculate p values, which were considered significant 
if ≤ 0.05. The sample sizes (biological replicates), specific statistical tests used, and the main effects of our statisti-
cal analyses for each experiment were detailed in each figure legend.
Data Availability. The datasets generated during and/or analyzed during the current study are available from 
the corresponding author on reasonable request.
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